Prevention of respiratory syncytial virus infection in infants. What has been done and where are we today?

Respiratory syncytial virus (RSV) infection is a frequent cause of morbidity and mortality in children. Recently, great advances have been made in the development of new monoclonal antibodies and vaccines thanks to the recognition of the structural conformation of virus proteins. The objective of th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Andes pediatrica : revista Chilena de pediatría 2023-12, Vol.94 (6), p.672-680
Hauptverfasser:	Novoa Pizarro, José M, Lindemann Tappert, Birte Christina, Luchsinger Farías, Vivian R, Vargas Munita, Sergio L
Format:	Artikel
Sprache:	spa
Schlagworte:	Antibodies, Monoclonal - therapeutic use Antibodies, Neutralizing Antibodies, Viral Female Humans Infant Pregnancy Respiratory Syncytial Virus Infections - genetics Respiratory Syncytial Virus Infections - prevention & control Respiratory Syncytial Virus Vaccines - genetics Respiratory Syncytial Virus Vaccines - therapeutic use Respiratory Syncytial Virus, Human - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!